Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 9,207 | 10,952 | 15,839 | 19,166 | 27,076 |
| Operating Income | -9,207 | -10,952 | -15,839 | -19,166 | -27,076 |
| Other Income | 6,447 | 9,778 | 6,738 | 430 | 353 |
| Pre-tax Income | -2,760 | -1,174 | -9,101 | -18,736 | -26,723 |
| Net Income Continuous | -2,760 | -1,174 | -9,101 | -18,736 | -26,723 |
| Net Income | $-2,760 | $-1,174 | $-9,101 | $-18,736 | $-26,723 |
| EPS Basic Total Ops | -0.10 | -0.04 | 0.33 | -1.13 | -1.74 |
| EPS Basic Continuous Ops | -0.10 | -0.04 | 0.33 | -1.13 | -1.74 |
| EPS Diluted Total Ops | -0.10 | -0.04 | 0.33 | -1.13 | -1.74 |
| EPS Diluted Continuous Ops | -0.10 | -0.04 | 0.33 | -1.13 | -1.74 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.38 | -0.32 | -1.13 | -1.74 |
| EBITDA(a) | $-9,186 | $-10,931 | $-15,549 | $-18,937 | $-26,818 |